Glenmark is a research‐led, global pharmaceutical company, with presence across branded, generics, and OTC segments; our focus therapy areas are Respiratory, Dermatology and Oncology. We are focused on developing bioequivalent as well as innovative medicines that make a difference to the NHS and fulfil the unmet needs of patients.
Visit the GLENMARK website. By clicking the link you will leave the PCPA website.
